iAnthus Capital Holdings, Inc. (CSE:IAN) Stock Catapults 50% Though Its Price And Business Still Lag The Industry
May 05
Canadian (TSX) Pharma Industry Analysis
UpdatedMay 09, 2024
DataAggregated Company Financials
Companies87
- 7D-6.5%
- 3M0.1%
- 1Y50.2%
- YTD34.1%
The Pharma industry is down 19% over the last week with Green Thumb Industries the worst performer, down 7.7%. In contrast, iAnthus Capital Holdings has gained 20%. Over the past 12 months, the industry was up 45%. Earnings are forecast to grow by 55% annually.
Industry Valuation and Performance
Has the Canadian Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 09 May 2024 | CA$23.4b | CA$11.9b | -CA$3,453,064,894.89 | 10.8x | -6.8x | 2x |
| Sat, 06 Apr 2024 | CA$24.6b | CA$11.9b | -CA$3,481,079,488.49 | 8.7x | -7.1x | 2.1x |
| Mon, 04 Mar 2024 | CA$21.7b | CA$12.0b | -CA$4,217,629,521.48 | 9.4x | -5.1x | 1.8x |
| Wed, 31 Jan 2024 | CA$22.7b | CA$12.3b | -CA$6,716,542,477.00 | 8.8x | -3.4x | 1.8x |
| Fri, 29 Dec 2023 | CA$17.7b | CA$12.2b | -CA$6,707,159,626.00 | 9.1x | -2.6x | 1.5x |
| Sun, 26 Nov 2023 | CA$17.8b | CA$12.4b | -CA$6,821,960,697.00 | 7x | -2.6x | 1.4x |
| Tue, 24 Oct 2023 | CA$16.8b | CA$12.4b | -CA$7,337,693,416.00 | 12x | -2.3x | 1.4x |
| Thu, 21 Sep 2023 | CA$20.7b | CA$12.9b | -CA$7,880,149,538.00 | 13.9x | -2.6x | 1.6x |
| Sat, 19 Aug 2023 | CA$13.9b | CA$13.0b | -CA$8,052,240,353.00 | 13.1x | -1.7x | 1.1x |
| Mon, 17 Jul 2023 | CA$16.0b | CA$13.2b | -CA$9,718,273,603.00 | 12.4x | -1.6x | 1.2x |
| Wed, 14 Jun 2023 | CA$14.6b | CA$13.2b | -CA$10,382,733,556.00 | 10.7x | -1.4x | 1.1x |
| Fri, 12 May 2023 | CA$14.8b | CA$13.3b | -CA$10,256,145,500.00 | 9.9x | -1.4x | 1.1x |
| Sun, 09 Apr 2023 | CA$15.5b | CA$13.3b | -CA$9,967,644,441.00 | 8.2x | -1.6x | 1.2x |
| Tue, 07 Mar 2023 | CA$19.9b | CA$13.7b | -CA$10,323,246,624.00 | 9.4x | -1.9x | 1.4x |
| Thu, 02 Feb 2023 | CA$20.5b | CA$13.5b | -CA$10,126,848,375.00 | 11x | -2x | 1.5x |
| Sat, 31 Dec 2022 | CA$19.9b | CA$13.6b | -CA$10,135,366,379.00 | 14.1x | -2x | 1.5x |
| Mon, 28 Nov 2022 | CA$30.1b | CA$13.4b | -CA$10,219,095,656.00 | 10.9x | -2.9x | 2.2x |
| Wed, 26 Oct 2022 | CA$28.0b | CA$13.4b | -CA$9,395,160,603.00 | 11.6x | -3x | 2.1x |
| Fri, 23 Sep 2022 | CA$26.6b | CA$13.3b | -CA$9,367,718,867.00 | 11.8x | -2.8x | 2x |
| Sun, 21 Aug 2022 | CA$30.0b | CA$13.0b | -CA$8,898,501,360.00 | 14.4x | -3.4x | 2.3x |
| Tue, 19 Jul 2022 | CA$26.8b | CA$12.3b | -CA$5,880,497,290.00 | 11x | -4.6x | 2.2x |
| Thu, 16 Jun 2022 | CA$28.4b | CA$12.2b | -CA$5,803,931,065.00 | 8.6x | -4.9x | 2.3x |
| Sat, 14 May 2022 | CA$126.8b | CA$12.0b | -CA$5,668,435,703.00 | 9.6x | -22.4x | 10.5x |
| Mon, 11 Apr 2022 | CA$41.9b | CA$11.6b | -CA$4,619,357,008.00 | 13.1x | -9.1x | 3.6x |
| Wed, 09 Mar 2022 | CA$39.8b | CA$10.8b | -CA$4,404,188,510.00 | 14.4x | -9x | 3.7x |
| Fri, 04 Feb 2022 | CA$46.2b | CA$10.9b | -CA$4,908,499,588.00 | 11.6x | -9.4x | 4.2x |
| Sun, 02 Jan 2022 | CA$53.5b | CA$10.8b | -CA$4,955,010,491.00 | 13.1x | -10.8x | 4.9x |
| Tue, 30 Nov 2021 | CA$60.0b | CA$10.9b | -CA$4,808,106,110.00 | 19.7x | -12.5x | 5.5x |
| Thu, 28 Oct 2021 | CA$58.7b | CA$10.1b | -CA$4,895,158,053.00 | 15.7x | -12x | 5.8x |
| Sat, 25 Sep 2021 | CA$68.1b | CA$10.4b | -CA$6,649,027,777.00 | 16.4x | -10.2x | 6.6x |
| Mon, 23 Aug 2021 | CA$68.1b | CA$10.2b | -CA$6,616,236,433.27 | 22.5x | -10.3x | 6.7x |
| Sat, 10 Jul 2021 | CA$83.0b | CA$10.2b | -CA$6,613,771,569.27 | 24.2x | -12.5x | 8.1x |
Price to Earnings Ratio
-10.9x
Current Industry PE
- Investors are pessimistic on the Canadian Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 3.0x is higher than the industry's current PS ratio of 2.0x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have improved over the last three years.
- Revenues for these companies have grown 10% per year.
- This means that more sales are being generated by these companies overall, and subsequently losses are decreasing too.
Industry Trends
Which industries have driven the changes within the Canadian Healthcare industry?
| CA Market | 3.09% | |
| Healthcare | -3.68% | |
| Pharma | -6.45% | |
| Pharma | -6.45% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| IAN iAnthus Capital Holdings | CA$0.03 | 20.0% +CA$33.1m | 20.0% | PS0.9x | |
| HITI High Tide | CA$3.26 | 8.3% +CA$19.8m | 83.1% | PS0.5x | |
| GUD Knight Therapeutics | CA$5.92 | 2.6% +CA$15.2m | 25.7% | PS1.8x | |
| ZYUS ZYUS Life Sciences | CA$1.19 | 19.0% +CA$13.5m | n/a | PS240.2x | |
| CPH Cipher Pharmaceuticals | CA$9.13 | 6.4% +CA$13.3m | 180.1% | PE7.9x |